Apotex submits supplemental ANDA for Imiquimod
Apotex Inc. has submitted a supplemental Abbreviated New Drug Application (ANDA091308) for Imiquimod.
Therapeutic Area
Therapeutic area intelligence for Topical Immunomodulator with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.